Follow-The-Filings

Security

Diamedica Therapeutics Inc. · COM NEW

Equity holders as of 2026 Q1 (each manager’s latest book)

6 owners 1 new 2 exits max 0.5% (Leon Cooperman - Omega Ad...)

owners 6
max % 0.5%
tracked value $27M
qoq N 1 A 3 R 1 E 2

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Leon Cooperman - Omega Advisors 2026 Q1 0.5% 2,020,000 $14M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 935,592 $6M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 723,120 $6M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 145,724 $987 hist
Renaissance Technologies LLC 2026 Q1 0.0% New 0.0% 52,523 $356 hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Reduce 0.00 pp 11,287 $76 hist
Marshall Wace - Marshall Wace, LLP exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 32,200 $256 hist
Dmitry Balyasny - Balyasny Asset Management L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 17,086 $136 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$19.38M -$24.44M -$32.77M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $53.68M $44.61M $60.63M
Total non-current assets $485,000 $1.74M $742,000
Total assets $54.16M $46.34M $61.37M
Total current liabilities $2.79M $5.39M $5.13M
Total non-current liabilities $317,000 $237,000 $128,000
Total equity $51.06M $40.72M $56.11M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$18.73M -$22.08M -$29.06M
Cash from investing -$18.3M $8.56M -$2.19M
Cash from financing $36.84M $11.99M $43.88M
Net change in cash -$185,000 -$1.52M $12.62M

ownership over time

filing count by report period · click a bar for that quarter’s holders